166 related articles for article (PubMed ID: 29629558)
1. δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer.
Shrestha N; Shrestha H; Ryu T; Kim H; Simkhada S; Cho YC; Park SY; Cho S; Lee KY; Lee JH; Kim K
Mol Cells; 2018 Apr; 41(4):320-330. PubMed ID: 29629558
[TBL] [Abstract][Full Text] [Related]
2. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling.
He Y; Ryu T; Shrestha N; Yuan T; Kim H; Shrestha H; Cho YC; Seo YW; Song WK; Kim K
Sci Rep; 2016 Feb; 6():21207. PubMed ID: 26883159
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer.
Wang B; Zhou R; Wu J; Kim H; Kim K
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119741. PubMed ID: 38697304
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.
Duan L; Raja SM; Chen G; Virmani S; Williams SH; Clubb RJ; Mukhopadhyay C; Rainey MA; Ying G; Dimri M; Chen J; Reddi AL; Naramura M; Band V; Band H
J Biol Chem; 2011 Jan; 286(1):620-33. PubMed ID: 20940296
[TBL] [Abstract][Full Text] [Related]
5. c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.
Chitalia V; Shivanna S; Martorell J; Meyer R; Edelman E; Rahimi N
J Biol Chem; 2013 Aug; 288(32):23505-17. PubMed ID: 23744067
[TBL] [Abstract][Full Text] [Related]
6. C-Src-mediated phosphorylation of δ-catenin increases its protein stability and the ability of inducing nuclear distribution of β-catenin.
He Y; Kim H; Ryu T; Lee KY; Choi WS; Kim KM; Zheng M; Joh Y; Lee JH; Kwon DD; Lu Q; Kim K
Biochim Biophys Acta; 2014 Apr; 1843(4):758-68. PubMed ID: 24412473
[TBL] [Abstract][Full Text] [Related]
7. Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Wisniewski DJ; Liyasova MS; Korrapati S; Zhang X; Ratnayake S; Chen Q; Gilbert SF; Catalano A; Voeller D; Meerzaman D; Guha U; Porat-Shliom N; Annunziata CM; Lipkowitz S
J Biol Chem; 2023 Jan; 299(1):102766. PubMed ID: 36470425
[TBL] [Abstract][Full Text] [Related]
8. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated EGFR ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract][Full Text] [Related]
9. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
10. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
[TBL] [Abstract][Full Text] [Related]
11. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
Zhou L; Yang H
PLoS One; 2011; 6(9):e23936. PubMed ID: 21949687
[TBL] [Abstract][Full Text] [Related]
12. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
13. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
Parks EE; Ceresa BP
J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
[TBL] [Abstract][Full Text] [Related]
14. αPIX Is a Trafficking Regulator that Balances Recycling and Degradation of the Epidermal Growth Factor Receptor.
Kortüm F; Harms FL; Hennighausen N; Rosenberger G
PLoS One; 2015; 10(7):e0132737. PubMed ID: 26177020
[TBL] [Abstract][Full Text] [Related]
15. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5.
Ryan PE; Kales SC; Yadavalli R; Nau MM; Zhang H; Lipkowitz S
PLoS One; 2012; 7(11):e49428. PubMed ID: 23145173
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.
Kwak SY; Kim BY; Ahn HJ; Yoo JO; Kim J; Bae IH; Han YH
FEBS J; 2015 Apr; 282(8):1512-25. PubMed ID: 25691332
[TBL] [Abstract][Full Text] [Related]
17. δ-Catenin Participates in EGF/AKT/p21
Shen Y; Lee HJ; Zhou R; Kim H; Chen G; Cho YC; Kim K
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069970
[TBL] [Abstract][Full Text] [Related]
18. Delta-catenin affects the localization and stability of p120-catenin by competitively interacting with E-cadherin.
Yang I; Chang O; Lu Q; Kim K
Mol Cells; 2010 Mar; 29(3):233-7. PubMed ID: 20108168
[TBL] [Abstract][Full Text] [Related]
19. Cbl and Cbl-b independently regulate EGFR through distinct receptor interaction modes.
Pinilla-Macua I; Sorkin A
Mol Biol Cell; 2023 Dec; 34(13):ar134. PubMed ID: 37903221
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]